Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for Fat Redistribution in Obese Women with T2D
NCT02118376Unknown
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Aug 2014
- Primary completion
- Dec 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of exenatide in type 2 diabetes mellitus (T2DM) and obesity, sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Dual energy X-ray absorptiometry at 3 months. Status: unknown.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT02118376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118376.